-
Risk Management During A Pandemic: How Pfizer’s Quality Management System Fared
Clinical Research News | Nothing quite tests a risk-based management approach like a global pandemic that few predicted. And for Pfizer’s Melissa Suprin, the COVID-19 pandemic was the first big test of the quality management system.
Jan 26, 2021
-
Five Variants of Disease, When Patient Stratification Scores Fail, Studies for Long COVID: COVID-19 Updates
Clinical Research News| The UK’s patient stratification score doesn’t hold up to scrutiny, Fauci and others encourage doctors to equip themselves to argue for vaccines, NIH launches a study of “Long COVID”, and more. Plus: Siemens, with German funding, sets up more COVID-19 treatment facilities for South Africa.
Jan 22, 2021
-
Drugs Targeting Cellular Aging May Prove Useful For Numerous Conditions
Clinical Research News | Fundamental aging processes appear to be root-cause contributors to multiple conditions, ranging from heart attacks and cancer to neurodegenerative disorders like Alzheimer’s disease. Now a series of clinical trials will look at whether senolytics— drugs targeting cellular aging—could affect many or perhaps all other aging mechanisms because they are interlinked.
Jan 21, 2021
